1.Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
2.Institute of Hospital Management, Wuhan University, Wuhan 430071, China
3.Department of Respiratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
4.Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
5.Institute of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng 475000, China
6.China Academy of Chinese Medical Sciences, Beijing 100700, China
7.China Center for Evidence Based Traditional Chinese Medicine (CCEBTCM), Beijing 100700, China
8.Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
9.Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
10.Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
11.Division of Medical Affairs, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
12.Division of Nursing Affairs, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
13.Office of Nosocomial Infection Control, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
14.Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
15.Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
16.Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON L8S 4L8, Canada
17.Department of Traditional Chinese Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
18.Global Health Institute, Wuhan University, Wuhan 430072, China
* zengxiantao1128@163.com;
wangyyanpublic@bta.net.cn;
wangxinghuan1965@163.com
纸质出版:2020-03
Scan QR Code
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)[J]. MMR, 2020,7(1):1-22.
Cite this article as: Jin et al.: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res, 2020, 7: 4
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)[J]. MMR, 2020,7(1):1-22. DOI: 10.1186/s40779-020-0233-6.
Cite this article as: Jin et al.: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res, 2020, 7: 4 DOI: 10.1186/s40779-020-0233-6.
In December 2019
a new type viral pneumonia cases occurred in Wuhan
Hubei Province; and then named "2019 novel coronavirus (2019-nCoV)" by the World Health Organization (WHO) on 12 January 2020. For it is a never been experienced respiratory disease before and with infection ability widely and quickly
it attracted the world’s attention but without treatment and control manual. For the request from frontline clinicians and public health professionals of 2019-nCoV infected pneumonia management
an evidence-based guideline urgently needs to be developed. Therefore
we drafted this guideline according to the rapid advice guidelines methodology and general rules of WHO guideline development; we also added the first-hand management data of Zhongnan Hospital of Wuhan University. This guideline includes the guideline methodology
epidemiological characteristics
disease screening and population prevention
diagnosis
treatment and control (including traditional Chinese Medicine)
nosocomial infection prevention and control
and disease nursing of the 2019-nCoV. Moreover
we also provide a whole process of a successful treatment case of the severe 2019-nCoV infected pneumonia and experience and lessons of hospital rescue for 2019-nCoV infections. This rapid advice guideline is suitable for the first frontline doctors and nurses
managers of hospitals and healthcare sections
community residents
public health persons
relevant researchers
and all person who are interested in the 2019-nCoV.
World Health Organization . WHO handbook for guideline development . 2nd ed ; 2019 . http://apps.who.int/medicinedocs/documents/s22083en/s22083en. pdf http://apps.who.int/medicinedocs/documents/s22083en/s22083en. pdf . Accessed 22 Jan 2020
Norris SL . WHO and rapid advice guidelines: history and future directions . 2013 . https://g-i-n.net/conference/past-conferences/10th-conference/monday/10-00-am-to-1-00-pm/norris-62.pdf/view https://g-i-n.net/conference/past-conferences/10th-conference/monday/10-00-am-to-1-00-pm/norris-62.pdf/view . Accessed 22 Jan 2020 .
Schünemann HJ , Zhang Y , Oxman AD , Expert Evidence in Guidelines Group . Distinguishing opinion from evidence in guidelines . BMJ. 2019 ; 366 : l4606 .
GRADE handbook , GRADE working group . 2013 . https://gdt.gradepro.org/app/handbook/handbook.html https://gdt.gradepro.org/app/handbook/handbook.html . Accessed 22 Jan 2020 .
Guyatt GH , Oxman AD , Vist GE , Kunz R , Falck-Ytter Y , Alonso-Coello P , et al . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations . BMJ. 2008 ; 336 ( 7650 ): 924 – 6 .
Legault K , Schunemann H , Hillis C , et al . McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome . J Thromb Haemost. 2018 ; 16 : 1656 – 64 .
Jin YH , Cai L , Cheng ZS , Cheng H , Deng T , Fan YP , et al . A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version) . Yixue Xinzhi. 2020 ; 30 ( 1 ): 35 – 64 . https://doi.org/10.12173/j.issn.1004-5511.2020.01.09 https://doi.org/10.12173/j.issn.1004-5511.2020.01.09 [Article in China] .
Chan JFW , Yuan S , Kok KH , To KKT , Chu HC , Yang J , et al . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster . Lancet . 2020 . https://doi.org/10.1016/S0140-6736(20)30154-9https://doi.org/10.1016/S0140-6736(20)30154-9 https://doi.org/10.1016/S0140-6736(20)30154-9https://doi.org/10.1016/S0140-6736(20)30154-9 .
Health Emergency Office of National Health Commission of the PRC . Update on the epidemic of novel coronavirus (2019-nCoV) infected pneumonia as at 24:00 on 26 January . http://www.nhc.gov.cn/xcs/yqfkdt/202001/3882fdcdbfdc4b4fa4e3a829b62d518e.shtml http://www.nhc.gov.cn/xcs/yqfkdt/202001/3882fdcdbfdc4b4fa4e3a829b62d518e.shtml . Accessed 26 Jan 2020 .
Zhou P , Yang XL , Wang XG , Hu B , Zhang L , Zhang W , et al . A pneumonia outbreak associated with a new coronavirus of probable bat origin . Nature . 2020 . https://doi.org/10.1038/s41586-020-2012-7https://doi.org/10.1038/s41586-020-2012-7 https://doi.org/10.1038/s41586-020-2012-7https://doi.org/10.1038/s41586-020-2012-7 .
Perlman S . Another decade, another coronavirus . N Engl J Med . 2020 . https://doi.org/10.1056/NEJMe2001126https://doi.org/10.1056/NEJMe2001126 https://doi.org/10.1056/NEJMe2001126https://doi.org/10.1056/NEJMe2001126 .
General Office of National Health Committee . Office of State Administration of Traditional Chinese Medicine . Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 4) . 2020 . http://bgs.satcm.gov.cn/zhengcewenjian/2020-01-28/12576.html http://bgs.satcm.gov.cn/zhengcewenjian/2020-01-28/12576.html . Accessed 29 Jan 2020 .
Zhu N , Zhang D , Wang W , Li X , Yang B , Song J , et al . A novel coronavirus from patients with pneumonia in China, 2019 . N Engl J Med . 2020 . https://doi.org/10.1056/NEJMoa2001017https://doi.org/10.1056/NEJMoa2001017 https://doi.org/10.1056/NEJMoa2001017https://doi.org/10.1056/NEJMoa2001017 .
General Office of National Health Committee . Office of State Administration of Traditional Chinese Medicine . Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 3) . 2020 . http://www.nhc.gov.cn/xcs/zhengcwj/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtml http://www.nhc.gov.cn/xcs/zhengcwj/202001/f492c9153ea9437bb587ce2ffcbee1fa.shtml . Accessed 24 Jan 2020 .
Information Office of the State Council . Information office to hold press conference on joint preventing and controlling the epidemic of novel coronavirus (2019-nCoV) infected pneumonia . 2020 . http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42478/index.htm http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/42478/index.htm . Accessed 26 Jan 2020 .
Huang C , Wang Y , Li X , Ren L , Zhao J , Hu Y , et al . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet . 2020 . https://doi.org/10.1016/S0140-6736(20)30183-5https://doi.org/10.1016/S0140-6736(20)30183-5 https://doi.org/10.1016/S0140-6736(20)30183-5https://doi.org/10.1016/S0140-6736(20)30183-5 .
Li L , Ren MJ , Zhang YY , Li WQ , Zhao HY , Liang LC , et al . Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS) . Yixue Xinzhi. 2020 ; 30 ( 1 ): 4 – 6 [Article in China] .
Disease Control and Prevention Bureau of National Health and Health Commission . Program for prevention and control of novel coronavirus (2019-nCoV) infected pneumonia (Trial Version 2) . 2020 . http://www.nhc.gov.cn/xcs/zhengcwj/202001/c67cfe29ecf1470e8c7fc47d3b751e88.shtml http://www.nhc.gov.cn/xcs/zhengcwj/202001/c67cfe29ecf1470e8c7fc47d3b751e88.shtml . Accessed 23 Jan 2020 .
World Health Organization . Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts . 2020 . https://www.who.int/publications-detail/home-care-forpatients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mildsymptoms-and-management-of-contacts https://www.who.int/publications-detail/home-care-forpatients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mildsymptoms-and-management-of-contacts . Accessed 24 Jan 2020 .
Kim JY , Song JY , Yoon YK , Choi SH , Song YG , Kim SR , et al . Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities . Infect Chemother. 2015 ; 47 ( 4 ): 278 – 302 .
Wang Y , Lin LK . An advice guideline recommended by central south hospital for the suspected patients of novel coronavirus (2019-nCoV) infected pneumonia and their close contactsas at home quarantine . 2020 . https://mp.weixin.qq.com/s/xFO10WAFB9OUnM7VN92R2w https://mp.weixin.qq.com/s/xFO10WAFB9OUnM7VN92R2w . Accessed 25 Jan 2020 .
World Health Organization . Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected . 2020 . https://www.who.int/publications-detail/infection-prevention-and-control-duringhealth-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125 https://www.who.int/publications-detail/infection-prevention-and-control-duringhealth-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125 . Accessed 26 Jan 2020 .
World Health Organization . WHO advice for international travel and trade in relation to the outbreak of pneumonia caused by a new coronavirus in China . 2020 . https://www.who.int/ith/2020-0901_outbreak_of_Pneumonia_caused_by_a_new_coronavirus_in_C/en/ https://www.who.int/ith/2020-0901_outbreak_of_Pneumonia_caused_by_a_new_coronavirus_in_C/en/ . Accessed 23 Jan 2020 .
Centers for Disease Control and Prevention . CDC: travelers’ health - novel coronavirus in China . 2020 . https://wwwnc.cdc.gov/travel/notices/watch/novel-coronavirus-china https://wwwnc.cdc.gov/travel/notices/watch/novel-coronavirus-china . Accessed 23 Jan 2020 .
Wang W , Hu H , Song L , Gong X , Qu Y , Lu Z . Image of pulmonary and diagnosis of atypicalnovel coronavirus (2019-nCoV) infected pneumonia: case series of 14 patients . Yixue Xinzhi. 2020 ; 30 ( 1 ): 7 – 9 [Article in China] .
Chan KS , Lai ST , Chu CM , Tsui E , Tam CY , Wong MM , et al . Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study . Hong Kong Med J. 2003 ; 9 ( 6 ): 399 – 406 .
Chu CM , Cheng VC , Hung IF , Wong MM , Chan KH , Chan KS , et al . Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings . Thorax. 2004 ; 59 ( 3 ): 252 – 6 .
Lai ST . Treatment of severe acute respiratory syndrome . Eur J Clin Microbiol Infect Dis. 2005 ; 24 ( 9 ): 583 – 91 .
Brigitte M , Arti B , Stephan A , Judith A , Bruno R , Christoph W , et al . MERSCOV disease associated ARDS -a case report . Crit Care Med. 2015 ; 43 ( 12 ): 308 .
Jiang H , Deng H , Wang Y , Liu Z , Sun WM . The possibility of using Lopinave/Litonawe (LPV/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies . Zhonghua Jizhen Yixue Zazhi. 2020 ; 29 ( 2 ): 182 – 6 [Article in China] .
Falzarano D , de Wit E , Rasmussen AL , Feldmann F , Okumura A , Scott DP , et al . Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques . Nat Med. 2013 ; 19 ( 10 ): 1313 – 7 .
Chan JF , Yao Y , Yeung ML , Deng W , Bao L , Jia L , et al . Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset . J Infect Dis. 2015 ; 212 ( 12 ): 1904 – 13 .
Omrani AS , Saad MM , Baig K , Bahloul A , Abdul-Matin M , Alaidaroos AY , et al . Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study . Lancet Infect Dis. 2014 ; 14 ( 11 ): 1090 – 5 .
Khan PA , Nousheen BB , Maryam N , Sultana K . Middle east respiratory syndrome (MERS): a systematic review . Int J Pharm Sci Res. 2018 ; 9 ( 7 ): 2616 – 25 .
Zhao ZW , Zhang FC , Xu M , Huang K , Zhong WN , Cai WP , et al . Clinical analysis of 190 cases of outbreak with atypical pneumonia in Guangzhou in spring, 2003 . Zhonghua Yixue Zazhi. 2003 ; 83 ( 9 ): 713 – 8 .
Meng QH , Dong PL , Guo YB , Zhang K , Liang LC , Hou W , et al . Use of glucocorticoid in treatment of severe acute respiratory syndrome cases . Zhonghua Yufang Yixue Zazhi. 2003 ; 37 ( 4 ): 233 – 5 [Article in China] .
Xiao JZ , Ma L , Gao J , Yang ZJ , Xing XY , Zhao HC , et al . Glucocorticoidinduced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy . Zhonghua Neike Zazhi. 2004 ; 43 ( 3 ): 179 – 82 [Article in China] .
ARDS Definition Task Force , Ranieri VM , Rubenfeld GD , Thompson BT , Ferguson ND , Caldwell E , et al . Acute respiratory distress syndrome: the Berlin Definition . JAMA. 2012 ; 307 ( 23 ): 2526 – 33 .
0
浏览量
0
Downloads
85
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621